Ampio Pharmaceuticals Inc. (AMPE) announced the exercise in full of the over-allotment option granted to the underwriters by Ampio and certain of its stockholders with respect to the purchase of 692,310 shares of common stock at a public offering price of $3.25 per share.
The over-allotment option is being exercised in connection with Ampio's previously announced underwritten public offering of 4.62 million shares of common stock, which was subsequently increased by 181,250 shares to an aggregate of 4.80 million such shares.
As a result of the exercise of the over-allotment option and the additional 181,250 shares of common stock purchased in the previously announced public offering, the total gross proceeds to Ampio from the offering will be approximately $16.91 million, before deducting the underwriting discount and other estimated offering expenses, Ampio said.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.